遠距基因組學市場－全球產業規模、佔有率、趨勢、機會和預測，按服務、專業領域、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球遠距基因體學市場規模為3.8881億美元，預計到2030年將以8.01%的複合年成長率成長至6.1734億美元。全球遠距基因組學市場涵蓋透過整合遠距醫療和基因組分析，遠端提供基因檢測、諮詢和解讀服務。該市場的成長主要得益於電信基礎設施的不斷進步，這些進步促進了無縫的遠距會診和高效的資料傳輸。此外，全球慢性病發病率的上升，需要透過基因資訊進行更及時的早期檢測和風險評估，這極大地推動了對遠距基因組學解決方案的需求。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球遠距基因體學市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按服務分類（按需存取、基因評估、檢測訂購、專家後續服務）
  • 按專業領域（癌症遺傳學、心血管遺傳學、主動遺傳學、生殖遺傳學、其他）
  • 按最終用戶分類（患者及其家屬、醫療專業人員、醫療和製藥公司、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美遠距基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲遠距基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區遠距基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲遠程基因組學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲遠程基因體學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球遠距基因體學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Tele-genomics Market, valued at USD 388.81 Million in 2024, is projected to experience a CAGR of 8.01% to reach USD 617.34 Million by 2030. The Global Tele-genomics Market encompasses the delivery of genetic testing, counseling, and interpretation services remotely through the integration of telemedicine and genomic analysis. This market's expansion is primarily driven by continuous advancements in telecommunication infrastructure, which facilitate seamless remote consultations and efficient data transmission. Furthermore, the rising global incidence of chronic diseases, requiring enhanced early detection and risk assessment through genetic insights, significantly fuels the demand for tele-genomics solutions.

Key Market Drivers

The increasing prevalence of chronic and genetic diseases constitutes a significant driver for the global tele-genomics market, necessitating more accessible and efficient diagnostic and counseling services. Conditions like heart disease, cancer, and diabetes, often with genetic predispositions, drive demand for early detection, risk assessment, and personalized treatment. According to the Centers for Disease Control and Prevention, in February 2024, an estimated 129 million people in the United States have at least one major chronic disease, with 42 percent affected by two or more, highlighting a substantial patient population poised for proactive genetic screening and personalized management. Tele-genomics directly addresses geographical and logistical barriers to specialized genetic services, enabling remote patient engagement vital for managing these widespread health challenges.

Key Market Challenges

The inherent complexity of data privacy concerns and the fragmented regulatory landscape across various jurisdictions represent a substantial impediment to the growth of the Global Tele-genomics Market. The highly sensitive nature of genomic information necessitates robust privacy frameworks. However, the absence of harmonized international and even intra-national regulations creates significant challenges for the secure and interoperable exchange of this critical data. This regulatory divergence complicates cross-border service delivery and hinders the establishment of standardized data sharing protocols, which are essential for large-scale genomic research and clinical application.

Key Market Trends

Two significant trends driving the global tele-genomics market are the increasing adoption of AI-powered genomic interpretation for remote consultations and the enhanced interoperability and data standardization for remote genomic platforms. Artificial intelligence is transforming the analysis of complex genomic data, making remote consultations more efficient and precise. This is evident as nearly 30% of the funding poured into healthcare startups in 2024 went to companies leveraging artificial intelligence, according to Silicon Valley Bank. Such investments underscore the growing recognition of AI's capability to process vast datasets and extract meaningful insights. AI-powered genomics has enabled precision medicine with 17.6% higher diagnostic accuracy in breast cancer detection, as reported by Forbes in September 2025. This directly translates into improved diagnostic services deliverable through tele-genomics.

Key Market Players

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

Report Scope:

In this report, the Global Tele-genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tele-genomics Market, By Services:

• On-Demand Access
• Genetic Assessment
• Test Ordering
• Expert Follow-Up

Tele-genomics Market, By Specialties:

• Cancer Genetics
• Cardio Genetics
• Proactive Genetics
• Reproductive Genetics
• Others

Tele-genomics Market, By End User:

• Patients & Their Families
• Health Professionals
• Health & Pharma Companies
• Others

Tele-genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tele-genomics Market.

Available Customizations:

Global Tele-genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tele-genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Services (On-Demand Access, Genetic Assessment, Test Ordering, Expert Follow-Up)
  • 5.2.2. By Specialties (Cancer Genetics, Cardio Genetics, Proactive Genetics, Reproductive Genetics, Others)
  • 5.2.3. By End User (Patients & Their Families, Health Professionals, Health & Pharma Companies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Tele-genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Services
  • 6.2.2. By Specialties
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tele-genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Services
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Tele-genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Services
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Tele-genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Services
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By End User

7. Europe Tele-genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Services
  • 7.2.2. By Specialties
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tele-genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Services
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By End User
  • 7.3.2. France Tele-genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Services
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Tele-genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Services
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Tele-genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Services
      • 7.3.4.2.2. By Specialties
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Tele-genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Services
      • 7.3.5.2.2. By Specialties
      • 7.3.5.2.3. By End User

8. Asia Pacific Tele-genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Services
  • 8.2.2. By Specialties
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tele-genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Services
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By End User
  • 8.3.2. India Tele-genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Services
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Tele-genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Services
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Tele-genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Services
      • 8.3.4.2.2. By Specialties
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Tele-genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Services
      • 8.3.5.2.2. By Specialties
      • 8.3.5.2.3. By End User

9. Middle East & Africa Tele-genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Services
  • 9.2.2. By Specialties
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tele-genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Services
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Tele-genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Services
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Tele-genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Services
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By End User

10. South America Tele-genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Services
  • 10.2.2. By Specialties
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tele-genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Services
      • 10.3.1.2.2. By Specialties
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Tele-genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Services
      • 10.3.2.2.2. By Specialties
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Tele-genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Services
      • 10.3.3.2.2. By Specialties
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tele-genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Genome Medical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. FDNA, Inc.
• 15.3. Illumina, Inc.
• 15.4. Informed Medical Decisions, Inc
• 15.5. Invitae Corporation
• 15.6. Pacific Radiopharmacy, Ltd.
• 15.7. NTP Radioisotopes SOC Ltd.
• 15.8. Lantheus Medical Imaging, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer